Article
Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study.
Korean journal of radiology - 1 Feb 2023
Park Yae Won, Park Ki Sung, Park Ji Eun, Ahn Sung Soo, Park Inho, Kim Ho Sung, Chang Jong Hee, Lee Seung-Koo, Kim Se Hoon
Abstract excerpt
OBJECTIVE: Cyclin-dependent kinase inhibitor (CDKN)2A/B homozygous deletion is a key molecular marker of isocitrate dehydrogenase (IDH)-mutant astrocytomas in the 2021 World Health Organization. We aimed to investigate whether qualitative and quantitative MRI parameters can predict CDKN2A/B homozygous deletion status in IDH-mutant astrocytomas. MATERIALS AND METHODS: Preoperative MRI data of 88 patients (mean age...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.